Catalyst Health Solutions Inc

Catalyst Health Solutions — Merger or Acquisition (April 2012)

13 slides from Catalyst Health Solutions's merger presentation, Apr 18, 2012

  1. Slide 1: Creating a Leading National Provider of PBM Services and Healthcare IT Solutions

    FILED BY SXC HEALTH SOLUTIONS CORP. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 The following is an investor presentation made by SXC Health Solutions Corp. on April 18, 2012. SUBJECT COMPANY: CATALYST HEALT

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements SXC Forward-Looking Statements Certain statements included in this communication, including those that express management’s expectations or estimates of SXC’s or the combined company’s future performance, constitute “forward-looking statements” within the meaning of applic

  3. Slide 3: Forward-Looking Statements cont.

    Forward-Looking Statements cont. Transaction Forward-Looking Statements In addition, numerous factors could cause actual results with respect to the proposed transaction to differ materially from those in the forward-looking statements, including without limitation, the possibility that the expected

  4. Slide 4: Strategically and Financially Compelling Transaction

    Strategically and Financially Compelling Transaction Combines two fast-growing complementary businesses to create a $13 billion leader in PBM services and healthcare information technology solutions Complementary products, services and solutions Distinct market segments served; combination will serv

  5. Slide 5: Transaction Summary

    Transaction Summary • Catalyst shareholders to receive $81.02 per share in cash and stock (based on the closing price of SXC’s stock on 4/17/12) Structure and • $28.00 in cash and 0.6606 shares of SXC stock Consideration • Implied premium of approximately 28% as of 4/17/12 • SXC shareholders expecte

  6. Slide 6: Significant Benefits to Catalyst Shareholders

    Significant Benefits to Catalyst Shareholders Strategic premium delivers immediate value to Catalyst shareholders 28% premium to closing price as of 4/17/12 Participation in upside potential of combined company Pro forma company expected to be owned 35% by Catalyst shareholders Enhanced growth poten

  7. Slide 7: Complementary Businesses

    Complementary Businesses Compelling Strategic Fit Comprehensive suite of best-in-class services and solutions Increased client diversity including large employers, managed care organizations, state and local governments, hospice, FFS Medicaid, long-term care, and workers’ compensation clients Enhanc

  8. Slide 8: Additional Size, Scale, and Broadened Scope

    Additional Size, Scale, and Broadened Scope Greater scale and scope increase purchasing efficiency and ability to drive lower costs to members Leading independent provider of flexible PBM solutions offers strong alternative to traditional PBMs SXC technology platform provides unlimited scalability I

  9. Slide 9: Capitalizing on the Opportunity

    Capitalizing on the Opportunity Plan sponsors increasingly focused on cost containment Recent transaction activity further elevates the need for scale to better serve clients Shift by MCOs toward integrated care models and hybrid PBM structures thus creating the need for an “unbundled”PBM offering I

  10. Slide 10: Financially Compelling Transaction

    Financially Compelling Transaction Combination creates an organization with $13 billion in revenue Expected to be highly accretive to SXC’s non-GAAP earnings in 2013 Combined company will have strong balance sheet and cash flow Creates flexibility to continue investing in growth initiatives while pa

  11. Slide 11: Expected Transaction Metrics

    Expected Transaction Metrics Integration expected to be completed 18 to 24 months following closing SXC expects $125 million in synergies achieved primarily through improved scale and operating leverage SXC expects $40-$45 million of integration expenses over the integration timeframe SXC expects th

  12. Slide 12: An Ideal Partnership

    An Ideal Partnership Combines two fast-growing, complementary businesses focused on lowering the cost of healthcare and improving patient outcomes Long history of working closely together to deliver value to clients Shared vision regarding customer-centered approach to client service Impressive trac

  13. Slide 13: Summary of Non-GAAP Financial Measures

    Summary of Non-GAAP Financial Measures SXC reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”). SXC’s management also evaluates and makes operating decisions using various other measures. Such measures are adjusted earnings per shar

Catalyst Health Solutions — Merger or Acquisition (April 2012) on 6ix